|
- KYMRIAH® (tisagenlecleucel) | Official Patient Website
What is KYMRIAH? KYMRIAH is made from your own white blood cells and is a prescription cancer treatment used in patients up to 25 years of age who have acute lymphoblastic leukemia (ALL) that is either relapsing (went into remission, then came back) or is refractory (did not go into remission after receiving other leukemia treatments)
- KYMRIAH® (tisagenlecleucel) | B-cell ALL Treatment
KYMRIAH ® (tisagenlecleucel) is a type of immunotherapy for patients with relapsed or refractory (r r) B-cell ALL Discover how KYMRIAH works, what makes it different from other therapies, and whether it could be right for you
- Pediatric ALL Treatment | KYMRIAH® (tisagenlecleucel)
KYMRIAH ® (tisagenlecleucel) is approved to treat children and young adults whose B-cell acute lymphoblastic leukemia (ALL) is refractory or in second or later relapse KYMRIAH is a therapy option for those looking for a different way to try to treat their cancer because previous treatments have not kept their cancer in remission
- Frequently Asked Questions | KYMRIAH® (tisagenlecleucel)
KYMRIAH is a type of cutting-edge immunocellular therapy This means that KYMRIAH harnesses the power of your own immune system to treat your advanced blood cancer KYMRIAH reprograms your T cells, natural defenders that are a part of your immune system T cells detect and destroy infected or cancerous cells by looking for certain antigens
- What to Expect With KYMRIAH® (tisagenlecleucel)
KYMRIAH is a therapy for children and young adults up to 25 years of age with B-cell ALL that is refractory or in second or later relapse Discuss your treatment history and overall health with your doctor to see if you are a candidate for KYMRIAH therapy
- Understanding KYMRIAH
What is KYMRIAH? KYMRIAH is made from your own white blood cells and is a prescription cancer treatment used in patients with follicular lymphoma (FL), a type of non-Hodgkin lymphoma, that has relapsed (went into remission, then came back) or is
- Diffuse Large B-cell Lymphoma (DLBCL) Treatment - KYMRIAH
KYMRIAH ® (tisagenlecleucel) is a treatment used in patients with non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL), that has relapsed or is refractory after having at least 2 other kinds of treatment
- How KYMRIAH® (tisagenlecleucel) May Help
KYMRIAH is an individualized treatment made just for you, using the inner strength of your own immune system to fight your cancer By reprogramming your T cells, KYMRIAH enhances their ability to detect and destroy your B cells, including those with cancer in them
|
|
|